Obinutuzumab (anti-CD20)
别名：Gazyva, GA101, Gazyvaro, Afutuzumab
中文名称：阿托珠单抗, 奥滨尤妥珠单抗
目录号：A2023 Purity: 99.65%
Obinutuzumab (Gazyva, GA101, Gazyvaro, Afutuzumab) (anti-CD20) 是一种新型的II型糖工程化人源化抗CD20的单克隆抗体，已开发用于治疗淋巴细胞白血病和B细胞起源的淋巴瘤。
点击购买Obinutuzumab (anti-CD20)相关产品的同型对照：
产品质控
抗体信息
| CAS号 | 949142-50-1 |
| 配制 | PBS buffer, pH 7.2 |
| 推荐同型对照 | Human IgG1 isotype control |
| 来源 | Humanized (from mouse) |
| 储存条件 (自收到货起) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
